| An Observational Registry of Abatacept in Patients with Juvenile Idiopathic Arthritis |
Ongoing |
Abatacept |
4 |
IM101240 |
King Abdulaziz Medical City NG (Riyadh) |
| An observational prospective study of switching asthma patients from a fixed-dose combination (FDC) Inhaled Corticosteroids [ICS] / Long-Acting Beta-Agonists [LABA] therapy delivered by pMDI Seretide® Evohaler to ICS/LABA delivered by pMDI Flutiform® |
Ongoing |
Flutiform |
4 |
FLT18-KSA |
King Fahad Medical City (Riyadh), Prince Sultan Military Medical City (Riyadh) |
| A multicenter, multinational, prospective, observational study to describe the clinical outcomes in patients with type 2 diabetes mellitus, treated with insulin glargine 300 U/mL (insulin glargine U300) before, during and after the period of Ramadan / ORION study |
Ongoing |
Toujeo |
4 |
OBS16040 |
King Abdulaziz University Hospital (Jeddah), Alzafer Hospital (Najran), University District Hospital (Jeddah), Saudi German Hospital (Jeddah) |
| An open label, Phase IV Multicentric Single Arm Study to Assess the Safety and Efficacy of BetazoleTM Cream Containing Betamethasone dipropionate (0.05% W/W) and Miconazole nitrate (2% W/W) in Subjects with Inflamed Skin Conditions of Eczema or Dermatitis 2ry Caused by Infection With Fungi |
Ongoing |
Betazole |
4 |
BETA001 |
King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh) |
| An open label, Phase IV, multicenter study to Assess the efficacy and safety of Elica-MTM Cream Containing Miconazole nitrate 2% w/w and Mometasone furoate 0.1% w/w) in Napkin Dermatitis with Inflamed Skin Conditions of Eczema or Dermatitis Caused by Infection With Certain Fungi and Bacteria |
Ongoing |
Elica-M |
4 |
ELICA-M001 |
King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh) |
| UPDATES: A prospective non-interventional study investigating the treatment effect of Tresiba® in adult patients with type 2 diabetes in Saudi Arabia |
Ongoing |
Tresiba |
4 |
NN1250-444 |
Dr. Soliman Fakeeh Hospital (Jeddah), Security Force Hospital (Riyadh), Umm Al-Qura University (Makkah), Dr. Sulaiman Al Habib Medical Group, King Fahad Medical City (Riyadh), Specialized Medical Center (Riyadh), Almana Hospital (Jubail), Saudi German Hospital (Jeddah), Almana Hospital (Ahsa), Almana Hospital (Khobar), Mouwasat Hospital (Qatif), Almana Hospital (Dammam), King Abdulaziz University Hospital (Jeddah), King Fahad Hospital of the University, My Clinic (Jeddah), United Doctors (Jeddah), Mouwasat Hospital (Khobar), Agrass Medical Complex (Jeddah) |
| MultiZonal obsERvational study conducted By clinIcal practitioners on Repatha® use iN subjects with hyperlipIdemia - ZERBINI |
Ongoing |
Repatha |
4 |
2016.03.27 |
Saud Al-Babtain Cardiac Center (Dammam), King Fahd Military Medical Complex (Dhahran), King Khalid University Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah), Armed Force Hospital (Taif), Armed Force Hospital (Khamis Mushait), Prince Sultan Cardic Center (Riyadh) |
| Post-authorization safety study in patients with type 2 diabetes mellitus to assess the incidence of ketoacidosis, severe complications of urinary tract infection, volume depletion, and dehydration among patients treated with EMPAGLIFLOZIN or DPP-4 inhibitors in Saudi Arabia |
Ongoing |
Jardiance |
4 |
1245/149 |
Armed Force Hospital (Al-Hada), King Fahad Medical City (Riyadh) |
| A single-arm interventional Phase IV, post-authorisationstudy evaluating the safety of pediatric patients withtransfusional hemosiderosis treated with deferasiroxcrushed film coated tablets |
Ongoing |
Deferasirox |
4 |
CICL670F24 |
King Abdulaziz Medical City NG (Jeddah) |
| Adjunct Low Dose Ketamine Infusion Versus Standard of Care in Mechanically Ventilated Critically Ill Patients at a Tertiary Saudi Hospital (ATTAINMENT Trial): Randomized, Prospective, Pilot Trial |
Ongoing |
Ketamine |
3 |
2191187 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
